The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Sep. 21, 2012
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Universite DE Strasbourg, Strasbourg, FR;

Inventors:

Martial Ruat, Orsay, FR;

Hélène Faure, Gif-sur-Yvette, FR;

Hermine Roudaut, Marly-la-Ville, FR;

Lucile Hoch, Auffargis, FR;

Angèle Schoenfelder, Lampertheim, FR;

Maurizio Taddei, Monteriggioni, IT;

André Mann, Ostwald, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 279/24 (2006.01); A61K 31/165 (2006.01); C07C 279/22 (2006.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07C 279/24 (2013.01); C07C 279/22 (2013.01); G01N 33/5011 (2013.01); G01N 33/5041 (2013.01); G01N 33/57492 (2013.01);
Abstract

The invention relates to compounds of formula (I), and the use thereof as a drug, particularly for the treatment of tumors associated with hyperactivation of the hedgehog protein signaling pathway, treatment of neurodegenerative diseases, treatment of diseases related to cerebral development (holoprosencephaly), for stem cell monitoring treatment of cerebrovascular accidents and cardiovascular accidents, treatment of diseases involving oligodendrocytes and diseases involving neurolemmocytes, for application thereof in vitro for modulating human or animal stem cell renewal, and for the treatment of diabetes. The invention also relates to pharmaceutical compositions having a compound of formula (I). The invention also relates to a method for radio-marking compounds having formula (I), the marked compounds, and the use of the compounds as research tools, and method for screening and/or identifying ligands in the Smoothened receptor (Smo) binding sites, methods for identifying agonists and antagonists of the Smoothened receptor, and a method for identifying cells.


Find Patent Forward Citations

Loading…